In the multivariable-adjusted results (model 2, Table 3) that included patient clinical characteristics (tumour grade, size and stage), the association became stronger [HR (95% CI), VHL = 0.33 (0.14–0.79), PBRM1 = 0.25 (0.08–0.79)]. This evidence concerns the gene PBRM1 and neoplasm.